Tumour‐associated macrophages act as a slow‐release reservoir of nano‐therapeutic Pt(IV) pro‐drug
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Therapeutic nanoparticles (TNPs) aim to deliver drugs more safely and effectively to cancers, yet clinical results have been unpredictable owing to limited in vivo understanding. Here we use single-cell imaging of intratumoral TNP pharmacokinetics and pharmacodynamics to better comprehend their heterogeneous behaviour. Model TNPs comprising a fluorescent platinum(IV) pro-drug and a clinically tested polymer platform (PLGA-b-PEG) promote long drug circulation and alter accumulation by directing cellular uptake toward tumour-associated macrophages (TAMs). Simultaneous imaging of TNP vehicle, its drug payload and single-cell DNA damage response reveals that TAMs serve as a local drug depot that accumulates significant vehicle from which DNA-damaging Pt payload gradually releases to neighbouring tumour cells. Correspondingly, TAM depletion reduces intratumoral TNP accumulation and efficacy. Thus, nanotherapeutics co-opt TAMs for drug delivery, which has implications for TNP design and for selecting patients into trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Miller et al. found a reduction in liver metastases due to enhanced delivery of nano‐encapsulated platinum in the TME via TAMs in a breast cancer mouse model [87].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
A global double-fluorescent Cre reporter mouse
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L., & Luo, L. (2007) · genesis · doi:10.1002/dvg.20335 · Cited by 3,491
The Chemistry of Fluorescent Bodipy Dyes: Versatility Unsurpassed
Ulrich, G., Ziessel, R., & Harriman, A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200702070 · Cited by 3,161
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Self-citationMacrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Cited by
Items 401–448 of 448
Probing in vivo drug release of macrophage-targeting liposomes
Xu, H., Su, Y.-W., Ma, H., Zeng, X. W., Wang, M., Chen, W., Chen, X., Zhou, Q., Li, Y., & Zheng, Y. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114941 · Cited by 1
Self-citationBio-nano: Theranostic at Cellular Level
Kluenker, M., Kurch, S., Tahir, M. N., & Tremel, W. (2018) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-94174-5_3 · Cited by 2
Tracking Biodistribution of Myeloid-Derived Cells in Murine Models of Breast Cancer
Li, J., Mai, J., Hinkle, L. E., Lin, D., Zhang, J., Liu, X., Ramirez, M., Zu, Y., Lokesh, G. L.-R., Volk, D. E., et al. (2019) · Genes · doi:10.3390/genes10040297 · Cited by 1
“In the meantime, the tumor infiltration properties of myeloid-derived cells also provide an avenue for delivery of cancer therapeutic agents using the cells as vehicles [7].”
BackgroundFluorescent Imaging for In Situ Measurement of Drug Target Engagement and Cell Signaling Pathways.
McMahon, N. P., Solanki, A., Jones, J., Kwon, S., Chang, Y.-H., Chin, K., Nederlof, M. A., Gray, J. W., & Gibbs, S. L. (2020) · PubMed · doi:10.1117/12.2546320 · Cited by 1
Applications of Iron Oxide Nanoparticles in the Magnetic Resonance Imaging for the Cancer Diagnosis
Akhtar, K., Javed, Y., Akhtar, M. I., & Shad, N. A. (2020) · Environmental chemistry for a sustainable world · doi:10.1007/978-3-030-44925-4_3 · Cited by 1
Confocal Imaging of Single-Cell Signaling in Orthotopic Models of Ovarian Cancer
Matvey, D., Ng, T. S. C., & Miller, M. A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1956-8_19 · Cited by 1
Self-citationTumor-Associated Macrophages: Therapeutic Targets of Cancer
Li, Y., Zhang, X., Zeng, X. L., Wang, S., & Wang, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-84164-5_13 · Cited by 1
Research Status of Immune Microenvironment in Triple Negative Breast Cancer
Liang, B. (2023) · SHS Web of Conferences · doi:10.1051/shsconf/202317403004 · Cited by 1
Reductive prodrug and AIE copolymer nanoparticle for monitoring and chemotherapy
Wang, Z., Li, G., Zhao, Q., Fu, G., Yang, Z., & Zhang, G. (2024) · BMC Cancer · doi:10.1186/s12885-024-12135-7 · Cited by 1
“Thus, a Pt( IV) complex can be conjugated to polymeric key joint and be released in a controlled fashion at tumor site, serving as both a drug and reduction-responsive moiety [32].”
BackgroundSubcellular Drug Depots as Reservoirs for Small-Molecule Drugs
Li, R., Weissleder, R., & Miller, M. A. (2021) · Methods in pharmacology and toxicology · doi:10.1007/978-1-0716-1250-7_18 · Cited by 1
Self-citationNgambenjawong, C. (2017) · ResearchWorks at the University of Washington (University of Washington)
Targeted therapeutics in inflammatory atherosclerosis
Alaarg, A. (2017) · doi:10.3990/1.9789036543835
Targeting and inhibition of tumor-associated macrophages in breast cancer
Binnemars‐Postma, K. (2017) · doi:10.3990/1.9789036544627
Impact du fractionnement de la radiothérapie sur le microenvironnement vasculaire tumoral
Clément-Colmou, K. (2018) · theses.fr (ABES) · doi:10.70675/07822952z3c4az41eaz9ef9z6eeac9686262
Fluorescent Imaging for In Situ Measurement of Drug Target Engagement and Cell Signaling Pathways
McMahon, N. P., Solanki, A., Jones, J., Kwon, S., Chang, Y.-H., Chin, K., Nederlof, M. A., Gray, J. W., & Gibbs, S. L. (2020) · Optics in the Life Sciences · doi:10.1364/microscopy.2020.mw4a.5
Barriers for Tumor Drug Delivery
Huang, Q., & Du, J. (2020) · Springer eBooks · doi:10.1007/978-981-15-5159-8_2 · Cited by 1
Bioinspired Drug Delivery System for Anticancer Therapy.
Hu, Q. (2018) · NCSU Libraries Repository (North Carolina State University Libraries)
Nanomedicines in cancer immunotherapy: challenges and opportunities
Tartey, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90750-7.00005-3
"Cell Membrane Nano Vesicles as Drug Carriers: Biomedical Applications"
Islam, M. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.42.006724
The Copper-Loaded Glucose Oxidase Nanomedicines for Chemodynamic Therapy of Hepatocellular Carcinoma
吴, 婷. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441126
Intravital microscopy for assessment of anti-tumor nanotherapeutic delivery
Ivanova, E., Naumenko, V., Garanina, A. S., & Abakumov, M. A. (2025) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2025.033
Mechanisms Underlying Tumor-Associated Macrophages (TAMs)-Facilitated Metastasis
Aleebrahim‐Dehkordi, E., Deravi, N., Fallahi, M. S., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_66 · Cited by 1
Wang, Z., Li, G., Zhao, Q., Fu, G., Yang, Z., & Zhang, G. (2024) · Figshare · doi:10.6084/m9.figshare.25485839
Su, C., Liu, S., Cao, S., Yin, S., Zhou, C., Gao, S., Jia, C., Ji, Y., & Liu, Y. (2020) · Figshare · doi:10.6084/m9.figshare.13212283
López-Valverde, J. A. (2024) · Deposito de Investigacion Universidad de Sevilla (University of Seville) · Cited by 1
Uudse antratsükliiniga laetud nano-osakesed vähi täppisteraapiaks
Sidorenko, V. (2024) · DSpace repository (University of Tartu)
Potentiation of Porphysome Photodynamic Therapy via an Unconventional Membrane Fluidization Strategy
Ho, T. (2025) · TSpace (University of Toronto)
Bouchaala, R. (2017) · theses.fr (ABES) · doi:10.70675/9302c022zf870z44ecz8280za1eda27f4601
Moro, S. (2023) · theses.fr (ABES) · doi:10.70675/448ebcaezb632z4399z9621z6dd72997c343 · Cited by 1
Hua, K., Li, X., Pan, Y., Li, Z., Li, D., Zheng, J., Chen, Y., Liu, J., Wang, Q., Li, Y., et al. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115695
Dash, S. K., Ghosh, R., & Jindal, A. B. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03447-x
“These macrophages then gradually release the drug into the interstitial fluid, thereby providing sustained systemic drug availability [65].”
Narimatsu, K., Yahata, M., Yamaguchi, M. S., Watanabe, T., & Miyawaki, I. (2026) · Journal of Liposome Research · doi:10.1080/08982104.2026.2700508
Picardi, M., Vincenzi, A., Giordano, C., Pugliese, N., Vigliar, E., Troncone, G., Cappiello, R., Mascolo, M., Mainolfi, C. G., Fonti, R., et al. (2026) · Annals of Hematology · doi:10.1007/s00277-026-07173-z
Miao, X., Yu, W., Liu, B., Sethi, G., Miao, X., Xiao, B., & Tao, H. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103493
“In the current study, as an important part of this novel strategy, macrophages have been reported to act as the ‘cellular drug reservoirs', transferring temporarily sequestered drugs into the neighboring tissues [16].”
Han, Y. R., & Lee, S. B. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2708061 · Cited by 1
Tumor-Derived HMGB1 Orchestrates Lysosomal Metabolic Reprogramming for M1 Macrophage Polarization
Zhang, G., Cao, Y., Wu, X., Liu, H., Zeng, M., Sun, X., Huang, S., Liang, J., Li, G., Shen, H., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01996
Ni, H., Fu, X., Chen, X., & Zhao, L. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1875872 · Cited by 1
“Systemically administered nanoparticles may be sequestered by monocytes and tumor-associated macrophages, although this effect has not been adequately validated for SeNPs (85).”
Cellular Transmigration Increases Nanoparticle Penetration Into Solid Tumors
Mladjenovic, S. M., Chang, A. C. Y., Blackadar, C., Ji, Q., Lekuti, A. A., Ahmed, S., & Chan, W. C. W. (2026) · ACS Nano · doi:10.1021/acsnano.5c21186
Enhanced transendothelial delivery of albumin-based carriers into tumors via macropinocytosis
Chen, Z., Yang, M., Guo, Y., Wang, Y., Rui, X., & Wu, J. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115299
Sharma, A., Kumar, A., Patel, P., & Kurmi, B. D. (2026) · Advanced Therapeutics · doi:10.1002/adtp.70167
STING signaling in liver diseases and the therapeutic potential of nanodrug delivery systems
Nie, S., Qian, X., Zhao, Y., Yao, T., Munyonyela, W. W., Zhang, H., Hu, M., Wu, S., Wu, G., Chen, P., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102453
Hu, H., Jiang, F., Park, S. J., Ge, X., Goemans, M., Kang, M., Scott, E., Gong, D. H., Quintana, J. M., Rodriguez, V. E., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.118010
Self-citationSescu, V. A., Filipescu, A., Solomon-Condriuc, I. P., Burac, M., Scripcariu, I. S., Socolov, D. G., Socolov, R. V., & Cărăuleanu, A. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18101218
(2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.57s.110
Heydari, F., Derakhshani, M., & Naghinezhad, J. (2026) · Journal of Hematology & Oncology · doi:10.1186/s13045-026-01861-z
Metadata
- Authors
- Miller, M. A., Zheng, Y.-R., Gadde, S., Pfirschke, C., Zope, H., Engblom, C., Kohler, R. H., Iwamoto, Y., Yang, K. S., Askevold, B., Kolishetti, N., Pittet, M., Lippard, S. J., Farokhzad, O. C., & Weissleder, R.
- Affiliations
- Harvard University (US)
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weissleder, Ralph
- ORCID
- Venue
- Nature Communications
- Published
- 2015-10-27
- Volume
- 6
- Issue
- 1
- Pages
- 8692-8692
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4711745
- OpenAlex
- W1874889006
- Cited by
- 441
- References
- 70
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 38 · 2023: 40 · 2022: 40 · 2021: 46 · 2020: 62 · 2019: 55 · 2018: 48 · 2017: 42 · 2016: 23
- FWCI
- 13.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- Deutsche Forschungsgemeinschaft (PF809/1-1, CA034992)
- National Institutes of Health (CA151884, U54-CA151884, CA034992, CA139980, PO1-CA139980)
- National Cancer Institute (CA-034992, CA139980, P50CA086355, R01CA164448, U54CA151884, P01CA139980, R37CA034992, CA151884, R01CA034992, P30CA014051, T32CA079443)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- tumour-associated macrophages, nanotherapeutics, pharmacodynamics, single-cell imaging, DNA damage response, slow drug release, TAM depletion, nanoparticle accumulation, cancer nanomedicine
- MeSH terms
- Animals, Antineoplastic Agents, Female, Humans, Macrophages, Mice, Inbred C57BL, Mice, Nude, Neoplasms, Platinum, Prodrugs, Drug Delivery Systems, Cell Line, Tumor, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.